Pamela Biondani
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 12
- Pancreatic and Hepatic Oncology Research 7
- Colorectal Cancer Surgical Treatments 4
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 8
-
- Renal cell carcinoma treatment 7
- Gastric Cancer Management and Outcomes 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- Filippo PietrantonioFilippo de BraudMaria Di BartolomeoDidier SamuelFederica PerroneEléonora De MartinManuela GariboldiIlaria Bossi
- Cited by
- OncologyHepatologyTransplantation
- Journals
- Journal of Clinical Oncology (4 papers)Cancer (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ItalyFranceNetherlands
In The Last Decade
Pamela Biondani
37 papers receiving 498 citations
Peers
Comparison fields: 5 of 57
- Oncology 341
- Hepatology 71
- Transplantation 18
- Cancer Research 79
- Pulmonary and Respiratory Medicine 162
Countries citing papers authored by Pamela Biondani
This map shows the geographic impact of Pamela Biondani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Biondani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Biondani more than expected).
Fields of papers citing papers by Pamela Biondani
This network shows the impact of papers produced by Pamela Biondani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Biondani. The network helps show where Pamela Biondani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pamela Biondani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 16 | |
| 2 | 2020 | 11 | |
| 3 | 2019 | 22 | |
| 4 | 2017 | 48 | |
| 5 | 2015 | 22 | |
| 6 | 2014 | 8 | |
| 7 | 2014 | 8 | |
| 8 | 2014 | 9 | |
| 9 | 2014 | 56 | |
| 10 | Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients. | 2014 | 4 |
| 11 | 2013 | 8 | |
| 12 | 2013 | 50 | |
| 13 | 2013 | 24 | |
| 14 | 2013 | 11 | |
| 15 | 2013 | 26 | |
| 16 | 2013 | 4 | |
| 17 | 2013 | 42 | |
| 18 | 2012 | 3 | |
| 19 | 2012 | 2 | |
| 20 | 2012 | 1 |
About Pamela Biondani
Pamela Biondani is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 505 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Renal cell carcinoma treatment (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Neuroendocrine Tumor Research Advances (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). The work is most often cited by research in Oncology (341 citations), Hepatology (71 citations) and Transplantation (18 citations). Pamela Biondani has collaborated with scholars based in Italy, France and Netherlands. Frequent co-authors include Filippo Pietrantonio, Filippo de Braud, Maria Di Bartolomeo, Didier Samuel, Federica Perrone, Eléonora De Martin, Manuela Gariboldi, Ilaria Bossi, Claudia Maggi and Emilio Bajetta. Their work appears in journals such as Journal of Clinical Oncology, Cancer and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.